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Skin fibroblasts from the shoulder and lower extrem-
ities of normal individuals, as well as from patients with 
pretibial myxedema (PTM) were grown in culture. When 
cells reached the monolayer stage, they were labeled 
with 3H-glucosamine and tested for hyaluronic acid syn-
thesis in the presence of either serum from PTM patients 
or normal human serum_ All the fibroblasts from the 
pretibial area synthesized 2 to 3 times more hyaluronic 
acid when incubated with PTM sera than when incu-
bated in normal human serum. Fibroblasts cultured from 
skin of the back or prepuce did not respond to PTM sera. 
This heat-stable, protease-sensitive, and dialyzable, fi-
broblast-stimulating factor is not a 7Sy-globulin. The 
enhanced sensitivity to PTM sera exhibited by fibro-
blasts from the lower extremities may explain why the 
lesions in this disease are restricted primarily to that 
area. 
Connective tissues provide a supportive framework or a pro-
tective covering for the organism and its internal organs. There 
are several varieties of connective tissues that adapt to perform 
different functions. All are formed by the differentiation of 
mesenchymal cells derived from embryonic mesoderm. Each 
type of connective tissue has distinct physical properties that 
appear to make it suitable for the function it performs. This 
specialization is the result of adaptation of connective tissue 
cells to the environment; that adaptation, in turn, modulates 
the type and proportion of the extracellular constituents sur-
rounding these cells. Fibroblasts, for example, are adapted to a 
dermal function, and synthesize a variety of fibrous proteins 
(collagen, elastin, reticulin) as well as an amorphous matrix 
composed of a complex mixture of proteins and negatively 
charged polysaccharide chains known as glycosaminoglycans. 
Connective tissue may be divided into 3 principal types on 
the basis of the nature of the intercellular material: fibrous or 
fibroelastic, cartilage, and bone. Fibrous connective tissue can 
be either dense or loose according to its fiber content. Dermis 
is an unorganized, dense fibrous tissue in which the collagen 
fibers are interwoven and able to resist strong multidirectional 
tensional stress. The basic cells of the less differentiated forms 
of connective tissues are the fibroblast; these spindle-shaped 
cells have a large nucleus and relatively scant cytoplasm. The 
cells synthesize hyaluronic acid and other glycosaminoglycans 
(acid mucopolysaccharides) of the ground substance as well as 
the fibrous proteins. 
Reprint requests to: Marcel E. Nimni, Ph.D., Department of Medi-
cine and Biochemistry, Rheumatic Disease Section, University of 
Southern California School of Medicine, Los Angeles, California 90033. 
This work was supported by grants (AM 16404, AM 10358, AM 
11727, GCRCRR-43, and fellowship grant AM 02036-03) from the 
National Institutes of Health, Bethesda, Maryland 20014. 
Dr. Cheung is currently at the Medical College of Wisconsin, Rheu-
matology Section, Milwaukee Wisconsin 53226, and Dr. Spolter is at 
the Veterans Administration Hospital, Sepulveda, California 91343. 
Abbreviations: 
PTM: pretibial myxedema 
SDS: sodium dodecyl sulfate 
12 
Only recently have we learned that not all collagen molecules 
within a given species are identical [1-5]. Most of the earlier 
work on collagen relied on skin, tendon, and bone as sources of 
readily available material for study. When investigators began 
to examine other tissues, such as cartilage, blood vessels, and 
basement membranes, it became apparent that different molec-
ular species of collagen could be isolated from such tissues. The 
Table shows the molecular form and chain composition of a 
variety of collagens identified in different tissues. Fig 1, on the 
other hand, illustrates the differences in chain composition as 
well as degree of glycosylation of the hydroxy lysine residues in 
2 distinct forms of collagen. 
The other major structural component of the extracellular 
matrix of connective tissues is the ground substance. This 
material results from the complex interactions, mostly of pro-
teoglycans, protein links, and hyaluronate, involved in the 
formation of aggregates [6-9]. The basic macromolecular struc-
ture, the proteoglycan, consists of a core protein to which a 
large number of chondroitin sulfate and keratan sulfate chains 
are covalently attached (Fig 2) [10- 14]. Each protein core 
carries approximately 100 chondroitin sulfate chains with an 
average molecular weight of about 2 x 10'1, and 30 to 60 keratan 
sulfate chains each of a molecular weight of about 4 to 8 X 103 • 
The average molecular weight of the proteoglycan monomer is 
2.3 x 106• Chondroitin sulfate chains are not evenly distributed 
along the peptide core but occur in clusters. Much of the 
proteoglycans have some protein, the hyaluronic-acid-binding 
region located at one end of the core. About 65% of the keratan 
sulfate chains occur in the keratan-sulfate-enriched region ad-
jacent to the hyaluronic-acid-binding region. More than 90% of 
.the chondroitin sulfate chains are attached to the chondroitin-
sulfate-enriched region located further from the hyaluronic-
acid-binding region. In the proteoglycan molecules, from bovine 
nasal cartilage, there seems to be a wide polydispersity in 
molecular weight since these can range from a few hundred 
thousand to more than 4 million. This range of molecular 
weights apparently results from a variation in the number of 
chondroitin sulfate chains bound to each core protein (Fig 2) . 
The polysaccharide chains are constrained by their attachment 
at one end to the core protein. For this reason, the intact 
macromolecules have hydrodynamic properties that are differ-
ent from those of the isolated polysaccharide chains. That the 
highly anionic chains, which extend out from the core in a 
radial fashion, cause these macromolecules to occupy large 
molecular domains in turn contributes to the retention of large 
amounts of fluid, an important function of the dermis. These 
physicochemical properties of proteoglycans provide such other 
tissues as cartilage with their essential properties of resilience 
and stiffness [6]. 
Most of our knowledge about the structure and function of 
proteoglycans comes from studies of cartilagenous structures. 
Information available on the proteoglycans in skin suggests that 
they are, in general, homologous. In cartilage the primary 
sulfated polysaccharide components are chondroitin and kera-
tan sulfates; in skin the major component is dermatan sulfate. 
The repeating disaccharide unit of dermatan sulfate is L-idu-
ronosyl-N-acetyl galactosamine 4-sulfate (Fig 3) [15]. We do 
not know whether the unique presence of this hybrid glycosa-
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Collagen types so far identified: their molecular conformation and 
tissue distribution 
Collagen Molecular form type 
I [lXI (I) ] 2lX2 
II [lXI (II)]3 
III [lX.(III)]3 
IV Mixture of various 
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FIG 1. Schematic representation of 2 well-characterized forms of 
collagen (type I above, type II below). 
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FIG 2. Schematic representation of a proteoglycan aggregate contain-
ing proteoglycan subunits and link proteins associated with a hyaluro-
nate backbone. 
minoglycan reflects a difference in the general organizational 
pattern of the proteoglycans in skin. Another feature of skin is 
that the proteoglycans are very closely associated with the 
collagen fibers, from which they are difficult to separate. In 
other connective tissues, such as cartilage and tendon, the small 
amount of hyaluronic acid is mainly found as a component of 
the aggregated proteoglycan complex [13]. In skin, it is a major 
component which can account for up to 60% of the total 
glycosaminoglycans. 
GRA YES' DISEASE 
This disorder is most often characterized by a diffuse enlarge-
ment of the thyroid gland, hypersecretion of thyroid hormone, 
and thyrotoxicosis. Because it is frequently associated with an 
inflammatory condition of the retro-orbital tissues producing 
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FIG 3. Repeating unit of derma tan sulfate (A) and Hyalw-onic acid 
(E). 
exophthalmos, the term exophthalmic goiter has frequently 
been used as a common descriptive term for Graves' disease. 
Pretibial myxedema (PTM), which is an infrequent manifes-
tation of Graves' disease, classically occurs as an asymptomatic 
plaquelike accumulation of glycosaminoglycans in the skin of 
the lower portion of the legs. Sometimes, similar lesions occur 
over the dorsal surface of the hands and foreal'ms. The primary 
substance in these lesions has been identified as hyaluronic acid 
[16]. Sisson reported that typical PTM lesions contain 6 to 16 
times more hyalul'Onic acid than is found in unaffected skin 
[17]. 
The genesis of the mucopolysaccharide lesions of PTM is 
unknown. Although most patients with PTM lesions show 
concurrent high titers of long-acting thyroid stimulator in the 
serum [18], there is no convincing evidence that PTM lesions 
are the result of an immunologic process [19,20]. The purpose 
of this report is to provide information on the ability of cultured 
fibroblasts from PTM lesions and from normal pretibial tissue 
to synthesize significantly increased amounts of hyaluronic acid 
in response to a factor present in t he sera of PTM patients . 
Some of the properties of this factor will be discussed . 
The PTM lesions developed in these patients concurrently 
with severe thyrotoxicosis and infIltrative ophthalmopathy 6 to 
7 yr before the study. All patients received multiple doses of 
1311 and have subsequently been kept in an euthyroid condition 
with exogenous thyroxine therapy. 
MATERIALS AND METHODS 
Punch biopsy specimens (4 mm) were obtained from involved pre-
tibial skin and uninvolved skin of the back; specimens from similar 
areas were also collected from normal individuals. The tissues were 
washed with Dulbecco's phosphate-buffered saline containing 100 U / ml 
of penicillin and 100 Jlgm/ml of streptomycin (1% P IS). Then they were 
minced with scalpels, explanted, and grown in 25-cm2 Falcon cultw-e 
flasks. Dulbecco's minimal essential medium (Gibco) was supplemented 
with 20% heat-inactivated human serum and 1% PIS, and maintained 
at pH 7.2 in a 10% CO2-90% air environment [21]. Cultures of human 
foreskin were established in the same way. When the primary cell 
cultures reached confluency, they were trypsinized and subcultured. 
To investigate the biosynthesis of total protein and collagen, we used 
third-passage monolayer cells subdivided into 2 sets. Each set was 
incubated in the presence of either 20% pooled sera (1 ml) from PTM 
patients or an equal amount of normal human serum to which 4 ml of 
medium containing 3H-proline (50 JlCi/ml), L-ascorbic acid (50 Jlg/ ml), 
BAPN (125 f.lg/m1), and 1% P / S had been added. After 24 hI' of 
incubation, the cell layers were separated from the medium and tryp-
sinized, pud cell counts were made. The cells were then sonicated and 
put back into the original medium. 200 f.ll of the suspension was 
removed, dilu ted to 1 ml with 1% NaCI/Tris buffer (pH 7.4) and 
dialyzed extensively against the same buffer. The nondialyzable radio-
activity was used as a measure of the protein synthesized in 24 hr. 
Duplicate samples were analyzed. 
An aliquot of the cell/ medium mixture was treated with pepsin (1 
mg/ ml) in 0.5 N acetic acid for 24 hr at 4°C and lyophilized. The pepsin 
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was inactivated by dissolution of the samples in 5 mI of cold 1 M NaCI-
50 mM Tris (pH 7.5) containing rat skin acid-soluble collagen (200 
f.Lg/mi) . The suspension was titrated to neutrality with a 2 M NaOH 
solution and dialyzed against salt/ Tris buffer at 4°C overnight. Insol-
uble material was removed by centrifugation at 10,000 X g for 1 hr. The 
radioactive collagen was purified by neutral and acid salt precipitation. 
The final precipitate was then dissolved and dialyzed against 0.5 M 
acetic acid, and the radioactivity recovered was used as a measure of 
total collagen synthesis. 
Cyanogen Bromide Cleavage 
Cyanogen bromide cleavage of collagen was performed under nitro-
gen for 4 hr at 30°C with a two- to fourfold (wt/ wt) excess of CNBr (10 
mg/ ml in 70% formic acid) [22]. For electrophoretically elu ted material, 
CNBr cleavage was performed after the addition of carrier-acid-soluble 
collagen consistent with loading 50 to 100 f.Lg of pep tides per gel and 
more than 100,000 counts per minute of radioactive collagen peptides 
[23]. 
SDS E lectrophoresis 
Both 5% (for separating CI chains) and 15% (for separating CNBr 
peptides) (wt/ vol) acrylamide gels were cross-linked with 0.1% bisac-
rylamide and catalyzed by 0.05% ammonium persulfate and 0.03% 
(vol/vol) N ,N,N,N-tetramethylethylenediamine. A continuous Tris-bo-
rate buffer [24] was used: 0.1 M Tris-0.075 M boric acid (pH 8.6)-0.1% 
sodium dodecyl sulfate (SDS). Samples containing either 5 to 50 Ilg of 
collagen or 50 to 100 Ilg of collagen CNBr peptides were dissolved in 20 
mM Tris-borate (pH 8.6)-2M urea - 2% SDS at 55°C for 1 hI'; 30 to 50 
III was added to each gel. Gels (5 X 105 mm) were electrophoresed at 
150 v for 3 to 3.5 hI' (5% gels) or at 240 v for 2 to 2.5 hr (15% gels). Gels 
for visual observation were fixed in fresh 1% aqueous glutaraldehyde 
for 3 hI' prior to staining. Radioactive gels were cut into 1-mm slices, 
hydrolyzed in 0.2 mI of 0.4 M NaOH at 55°C overnight, and counted in 
acidified Aquasol [21,23]' 
Electrophoretic Elution 
We prefractionated samples for CNBr peptide analysis on 5% gels, 
sliced them, and held them « 2 days) at 4°C in a moist environment 
until we had determined the exact positions of the peaks by counting 
a rep licate gel. Slices from each peak were placed in an electroelution 
tube consisting of a glass tube (6 mm inside diameter X 180 mm) filled 
with Tris-borate buffer, a porous disk 1.5 em from the bottom of the 
tube, and a dialysis membrane bottom. Electroelution was performed 
at 300 v for 6 hr with tap water as coolant. Eluted samples were 
removed from between the dialysis membrane and the porous disk, 
centrifuged for the removal of any gel particles, dialyzed overnight 
against 0.1% NaDodSO" at room temperature, and lyophilized [23]. 
Recovery of eluted material was 90%. 
Hyaluronic Acid Biosynthesis 
To investigate the biosynthesis of hyaluronic acid by cultured fibro-
blasts, we used third-passage monolayer cells subdivided in to 2 sets. 
Each set was incubated in the presence of either 20% sera (1 ml) from 
PTM patients or an equal amount of normal human sera to which 4 ml 
of medium conta ining 3H-glucosamine (100 IlCi/ml), L-ascorbic acid (50 
f.Lg/ ml) , and 1% P / S had been added. After 24 hr of incubation, the cell 
layers were separated from the medium and trypsinized, and the cells 
were counted. The cells were sonicated and put back into the original 
medium. The mixture was then dialyzed extensively against 1% 
NaC1/0.05 M Tris (pH 7.4) , ethanol-precipitated, and deproteinized by 
incubation of the precipitate in a pronase buffer (0.1 M Tris (pH 7.4), 
0.001 M CaCh, and 3 mg of pronase/mI) at 55°C for 24 hr. Pronase was 
inactiva ted by boiling, and the sample solutions were then reprecipi-
tated by addition of 5 vol of ethanol. This purified precipitate was 
dissolved in and dialyzed against the saline/Tris buffer. Total hyalu-
ronic acid synthesis for the cells and medium was estimated by incu-
bation of 250 f.LI of this purified radioactively labeled sample with an 
equal volume of 0.1 M Na2HPO.-KH2PO. (pH 6.1), 0.30 M NaCI, and a 
bacterial hyaluronidase preparation (Varidase) solu tion for 2 hr a t 
37°C. The reaction mixtures were ethanol-precipitated, dissolved, and 
dialyzed extensively against the saline/ Tris buffer. The differences in 
radioactivity observed before and after hyaluronidase treatment were 
used as the tota l amount of hyaluronic acid produced during incubation. 
Biosynthesis of Sulfated Glycosaminoglycans 
The ability of fibroblasts to synthesize sulfated glycosaminoglycans 
was determined as each set of third-passage cells was incubaterl in the 
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presence of either 20% sera (1 ml) from PTM patients or an equal 
amount of normal human sera to which 4 ml of medium containing 
3"SO" (100 IlCi / mI) , L-ascorbic acid (50 Ilg/ ml), and 1% PIS had been 
added. After 24 hr of incubation, the cell layers were separated from 
the medium and trypsinized, and cell counts were obtained. After 
sonication, precipitation, and pronase digestion (see above) , 35S radio-
activity was determined in the purified precipitate. The final count was 
used as the tota l 35S0. glycosaminoglycan production. Immunoglobulin 
fractions from the serum were isolated by the method of Smith and 
Hall [25] or by a modified procedure with diethylaminoethyl cellulose 
chromatography (see Peterson and Sober [26]) . The purity of the latter 
preparation was verified by immunoelectrophoresis, which identifies 
only 1 precipitant band when run against antihuman antisera. Protein 
concentration was determined by the method of Lowry [27]. The 
normal human pooled sera employed in this study were developed from 
samples from 10 healthy, young, euthyroid adults without personal or 
family history of thyroid disease. 
RESULTS 
The rates of protein and collagen synthesis by human fibro-
blasts were measured by the uptake of tritiated proline. The 
effect of the presence of either normal pooled sera or sera from 
patients with PTM is summarized in Fig 4. The results clearly 
show that the only cells that exhibited an enhanced response 
were those originating from t h e pretibial area and grown in t h e 
presence of sera of PTM patients. Cells that originated from 
the back tissue of normal individuals or from foreskin tissue 
obtained at the time of birth did not respond. Their ability to 
synthesize both total protein and collagen were stimulated to 
approximately the same extent. 
The localization of the proteins synthesized by normal fibro-
blasts in culture in the presence of normal sera or sera from 
PTM patients is summarized in Fig 5. In both instances, most 
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FIG 4. Protein and collagen synthesis by cultured fibroblasts obtained 
from the pretibial area of a patient with pretibial myxedema (PTM) , 
and incubated in the presence of pooled sera from patients with PTM 
or normal controls. 
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FIG 5. Total protein synthesis by cultured fibroblasts obtained from 
the pretibial area of a normal volunteer. Cells were incubated either 
with normal sera (N) or sera from pretibial myxedema (PTM) patients. 
The protein synthesized was either identified with the cell layer or 
recovered from the medium. 
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of the radioactive protein could be recovered from the m edium. 
It seems clear that in either th e cell layer or the medium, t he 
sera obtained from the PTM patients were able to raise signifi-
cantly the amount of protein synthesized . 
The isolated and purifieq collagenous component was exam-
ined by SDS electrophoresis. Figure 6 shows the radioactive 
proflles obtained when human dermal fibroblasts originating 
from the pretibial area of a patient with PTM were incubated 
in the presence of normal sera or sera from patients with the 
disease. No differences were observed. In both instances, ap-
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FIG 6. Sodium dodecyl sulfate on polyacrylamide gel electrophoresis 
of collagen synthesized by pretibial fibroblasts from a patient with 
pretibial myxedema (PTM) were incubated with either normal sera 
(--)01' PTM sera (- - - - - - ). 
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FIG 7. Spectrophotometric scans of gels containing eNBr peptides 
from purified lX, (I), lX, (II) , and reduced lX, (III) chains. We used this 
profUe to characterize the ~, (1) and lX' (III) chains shown in Fig 6. 
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proximately 5% of the collagen synthesized was type III colla-
gen; the rest, which consisted of lX, and lX2 chains in a ratio that 
approximated 2:1, was characteristic of type I collagen. 
The identity of these chains was confIrmed by electroelution 
and treatment of the recovered peptides with CNBr followed 
by electrophoretic separation on sodium dodecyl sulfate by a 
polyacrylamide gel columns with 15% cross-linked gels. 
Figure 7 shows a standard run similar to that used for the 
unequivocal identifIcation of the chain that eluted in the lX, 
position before reduction and alkylation of the specimen. The 
presence of peptide lX, (I)-CB6 is a specific marker for lX, (I) 
collagen chains, and thus this experimental approach confIrmed 
that lX] (I) was the only contributor to the lX, peak seen in Fig 
5 [23). The presence of lX, (III) -CB5 + 9 or disappearance of the 
(lX,[IIIJb peak after reduction and alkylation confIrmed the 
presence of the smaller proportions of type III collagen [23). 
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FIG 8. Hyaluronic acid biosynthesis. Production of hyaluronic acid 
by fibroblasts originating from the pretibial al'ea of patients with' 
myxedema. The medium in which these cells grew was supplemented 
with pooled sera from normal individuals or from these patients. The 
pretibial myxedema (PTM) sera were fractionated or inactivated by a 
variety of means. Supplements were as follows: (1) normal human sera; 
(2) PTM sera; (3) PTM sera heated to l00 0 e for 5 min; (4) PTM 
sera-dialyzed; (5) PTM sera-pronase-treated for 18 hI' at 55°e (3 mg 
of enzyme/ ml) followed by heat inactivation of enzyme at 1000 e for 5 
min; (6) purified 7Sy-globulin fraction of PTM sera added to normal 
human sera (8 mg/ ml) ; (7) r.ormal human sera; and (8) PTM sera. The 
vertical bar represents the SD of 6 determinations. 
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FIG 9. Fibroblasts 3 sources: pretibial, shoulder, and foreshin) were 
grown from 2 normal, healthy individuals. The amount of hyaluronic 
acid produced by cells incubated with pretibial myxedema (PTM) sera 
was expressed as a percentage above that labeled in the presence of 
control normal sera. The vertical bars represent the SD of 6 to 10 
determinations. Hatched columns indicate normal sera and open col-
umns indicate pretibial myxedema sera. 
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Figure 8 summarizes the changes in the hyaluronic acid 
biosynthesis by fibroblasts obtained from patients with PTM. 
Primary cultures were initiated from skin obtained either from 
the edematous pretibial area or from the noninvolved shoulder 
area. The tissue culture medium was supplemented either with 
normal human sera or with sera from patients with PTM 
treated in a variety of ways for the purpose of inactivating their 
biological activities. When the response to normal human sera 
is used as a reference, the stimulating activity exhibited by the 
serum from the patients with PTM becomes very clear. It is 
evident that only the cells originating from the pretibial area 
responded selectively to the serum factor, since the fibroblasts 
obtained from the shoulder of these patients were not stimu-
lated. Heating the sera to 100°C for 5 min did not inhibit this 
effect, whereas dialysis and pronase treatment did. A purified 
7S-globulin fraction obtained from the sera of the PTM patients 
had no stimulatory activity. Because of the tissue specificity 
associated with this finding, we decided to investigate this 
phenomena further to find out if similar behavior would be 
exhibited by fibroblasts originating from the pretibial and 
shoulder areas of normal volunteers. 
Foreskin .fibroblasts obtained from newborns were also 
screened (Fig 9). We found that the factor present in the sera 
of PTM patients is not only able to stimulate selectively pre-
tibial cells from the edematous regions of patients suffering 
from this disease, but also is able to stimulate cells from the 
pretibial area of normal individuals. On the other hand, the 
serum factor failed to affect either the cells from the shoulder 
area of normal individuals or foreskin fibroblasts from new-
borns. 
The distribution between the cell layer and the medium of 
the hyaluronic acid synthesized by normal pretibial fibroblasts 
in the presence of normal sera or sera from patients with PTM 
can be seen in Fig 10. Although in both instances a stimulation 
of hyaluronic synthesis by PTM sera was detected, the major 
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FIG 10. Hyaluronic acid biosynthesis by fibroblasts grown in the 
presence of normal pooled sera (N) or from two patients with pretibial 
myxedema (1 and 2). Both cell layer and medium were assayed sepa-
rately. 
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FIG 11. Biosynthesis of sulfated glycosaminoglycans by pretibial 
fibroblasts of a patient with pretibial myxedema (PTM) incubated in 
the presence of normal serum and that of the PTM patient. Both cell 
layer and medium were assayed separately. 
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difference resided in the fraction of hyaluronic acid that was 
isolated from the medium. It is apparent that heating of the 
sera of the PTM patients to 55°C did not destroy the stimula-
tory activity. 
Sera from patients with PTM also stimulated the synthesis 
of sulfated glycosaminoglycans by pretibial fibroblasts originat-
ing from the involved area of a patient with PTM. 
The distribution of sulfated glycosaminoglycans between the 
medium and the cell layer was equal (Fig 11). In both instances, 
a slight increase in 35S uptake into the glycosaminoglycan-
containing fraction was observed when PTM sera were added. 
DISCUSSION 
These findings may be the first to shed light on the reasons 
for the localization of edematous lesions seen in patients with 
PTM. The patients in this study had thyroid ablation by 1311 
therapy and were placed on 0.2 mg of L-thyroxine/day to 
restore the blood levels to normal, measured as serum thyroxine 
and free thyroxine values. They also suggest that fibroblasts 
from different regions of the body may possess different char-
acteristics and their growth may be modulated by specific 
humoral factors. 
Several polypeptide growth factors that are able to stimulate 
growth of cells in culture have been described. Some of these 
have been isolated from blood fractions [28-30], submaxillary 
gland [31,32], pituitary gland [33-35], and cartilage [36]. Pre-
sumably, these growth factors act as hormones and are trans-
ported to their target cells by the blood stream. Castor et al 
[37] recently described a polypeptide, isolated from platelets of 
human serum, that can stimulate fibroblasts in culture (a) to 
increase the synthesis of hyaluronic acid and DNA and (b) to 
accelerate glycolysis. Whether the serum fibroblast stimulatory 
factor found in the patients with PTM will prove to be of a 
similar character awaits further chemical investigation. 
We wish to thank Dr. Paul Benya for his helpful comments and 
advice. 
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Laboratory Training Courses 
The Bureau of Laboratories of the Center for Disease Control, Atlanta, Georgia, will offer a series of 
laboratory training courses of varying duration (2 days to 2 weeks) in specific areas beginning on July 10, 
1978 through June 29, 1979. Information and application forms may be obtained from the Registrar, 
Bureau of Laboratories, Center for Disease Control, Atlanta, Georgia 30333. 
